Lake Street Initiates Coverage On Kura Oncology with Buy Rating, Announces Price Target of $23

Lake Street analyst Daniel Brims initiates coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and announces Price Target of $23.